ATAI Price To Sales Ratio vs Capex To Operating Cash Flow Analysis

ATAI Stock

USD 1.69 0.01 0.60%

ATAI Life financial indicator trend analysis is way more than just evaluating ATAI Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ATAI Life Sciences is a good investment. Please check the relationship between ATAI Life Price To Sales Ratio and its Capex To Operating Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Price To Sales Ratio vs Capex To Operating Cash Flow

Price To Sales Ratio vs Capex To Operating Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ATAI Life Sciences Price To Sales Ratio account and Capex To Operating Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between ATAI Life's Price To Sales Ratio and Capex To Operating Cash Flow is -0.42. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Capex To Operating Cash Flow in the same time period over historical financial statements of ATAI Life Sciences, assuming nothing else is changed. The correlation between historical values of ATAI Life's Price To Sales Ratio and Capex To Operating Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of ATAI Life Sciences are associated (or correlated) with its Capex To Operating Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Operating Cash Flow has no effect on the direction of Price To Sales Ratio i.e., ATAI Life's Price To Sales Ratio and Capex To Operating Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.42

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing ATAI Life Sciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on ATAI Life sales, a figure that is much harder to manipulate than other ATAI Life Sciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Capex To Operating Cash Flow

Most indicators from ATAI Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ATAI Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

As of now, ATAI Life's Tax Provision is increasing as compared to previous years. The ATAI Life's current Selling General Administrative is estimated to increase to about 68.8 M, while Issuance Of Capital Stock is projected to decrease to 0.00.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	47K	168K	319K	335.0K
Interest Income	205K	548K	1.4M	1.4M

Depreciation And Amortization Interest Income

ATAI Life fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Long Term Investments
Total Assets		0.66	0.82	0.96	-0.11	0.93	0.99	0.62	-0.75	-0.9	0.92	0.8	0.55	0.9	0.66	0.97	-0.82	0.94	0.97	0.83	-0.78	0.76	0.97	0.86	0.49	0.47
Short Long Term Debt Total	0.66		0.87	0.76	0.65	0.4	0.65	0.97	-0.04	-0.91	0.58	0.11	0.82	0.82	1.0	0.56	-0.57	0.78	0.76	0.23	-0.25	0.9	0.8	0.27	0.88	0.79
Other Current Liab	0.82	0.87		0.93	0.41	0.6	0.81	0.78	-0.39	-0.96	0.76	0.46	0.57	0.94	0.88	0.76	-0.78	0.93	0.87	0.52	-0.53	0.76	0.93	0.56	0.86	0.51
Total Current Liabilities	0.96	0.76	0.93		0.08	0.85	0.95	0.7	-0.64	-0.96	0.93	0.7	0.58	0.98	0.76	0.92	-0.9	0.97	0.94	0.71	-0.67	0.79	0.98	0.74	0.63	0.49
Total Stockholder Equity	-0.11	0.65	0.41	0.08		-0.42	-0.12	0.58	0.62	-0.32	-0.19	-0.57	0.37	0.19	0.65	-0.19	0.07	0.13	0.06	-0.43	0.32	0.32	0.13	-0.4	0.76	0.41
Other Liab	0.93	0.4	0.6	0.85	-0.42		0.92	0.41	-0.86	-0.72	0.94	0.88	0.44	0.8	0.4	0.94	-0.83	0.78	0.83	0.83	-0.73	0.63	0.81	0.85	0.15	0.35
Net Tangible Assets	0.99	0.65	0.81	0.95	-0.12	0.92		0.63	-0.73	-0.89	0.93	0.78	0.57	0.89	0.66	0.95	-0.81	0.95	0.98	0.81	-0.75	0.77	0.96	0.83	0.5	0.5
Property Plant And Equipment Net	0.62	0.97	0.78	0.7	0.58	0.41	0.63		0.04	-0.86	0.6	0.03	0.93	0.78	0.96	0.49	-0.58	0.73	0.71	0.12	-0.11	0.96	0.74	0.17	0.77	0.92
Net Debt	-0.75	-0.04	-0.39	-0.64	0.62	-0.86	-0.73	0.04		0.43	-0.7	-1.0	0.07	-0.53	-0.05	-0.85	0.6	-0.57	-0.63	-0.95	0.9	-0.17	-0.6	-0.95	0.04	0.17
Retained Earnings	-0.9	-0.91	-0.96	-0.96	-0.32	-0.72	-0.89	-0.86	0.43		-0.84	-0.5	-0.72	-0.97	-0.91	-0.84	0.8	-0.95	-0.93	-0.56	0.55	-0.89	-0.97	-0.6	-0.77	-0.66
Accounts Payable	0.92	0.58	0.76	0.93	-0.19	0.94	0.93	0.6	-0.7	-0.84		0.73	0.6	0.91	0.58	0.88	-0.95	0.89	0.86	0.67	-0.57	0.77	0.89	0.7	0.35	0.51
Cash	0.8	0.11	0.46	0.7	-0.57	0.88	0.78	0.03	-1.0	-0.5	0.73		-0.01	0.58	0.12	0.88	-0.63	0.62	0.68	0.96	-0.91	0.24	0.66	0.96	0.03	-0.11
Non Current Assets Total	0.55	0.82	0.57	0.58	0.37	0.44	0.57	0.93	0.07	-0.72	0.6	-0.01		0.66	0.81	0.4	-0.54	0.62	0.61	0.02	0.04	0.96	0.62	0.06	0.51	0.99
Non Currrent Assets Other	0.9	0.82	0.94	0.98	0.19	0.8	0.89	0.78	-0.53	-0.97	0.91	0.58	0.66		0.82	0.86	-0.92	0.93	0.89	0.58	-0.54	0.84	0.95	0.62	0.65	0.58
Long Term Debt	0.66	1.0	0.88	0.76	0.65	0.4	0.66	0.96	-0.05	-0.91	0.58	0.12	0.81	0.82		0.56	-0.57	0.78	0.76	0.24	-0.26	0.89	0.81	0.28	0.88	0.78
Cash And Short Term Investments	0.97	0.56	0.76	0.92	-0.19	0.94	0.95	0.49	-0.85	-0.84	0.88	0.88	0.4	0.86	0.56		-0.79	0.86	0.92	0.9	-0.86	0.63	0.91	0.92	0.4	0.31
Net Receivables	-0.82	-0.57	-0.78	-0.9	0.07	-0.83	-0.81	-0.58	0.6	0.8	-0.95	-0.63	-0.54	-0.92	-0.57	-0.79		-0.82	-0.74	-0.53	0.44	-0.7	-0.82	-0.57	-0.38	-0.45
Common Stock Total Equity	0.94	0.78	0.93	0.97	0.13	0.78	0.95	0.73	-0.57	-0.95	0.89	0.62	0.62	0.93	0.78	0.86	-0.82		0.97	0.66	-0.63	0.81	0.99	0.7	0.7	0.55
Common Stock Shares Outstanding	0.97	0.76	0.87	0.94	0.06	0.83	0.98	0.71	-0.63	-0.93	0.86	0.68	0.61	0.89	0.76	0.92	-0.74	0.97		0.76	-0.74	0.8	0.98	0.79	0.64	0.54
Non Current Liabilities Total	0.83	0.23	0.52	0.71	-0.43	0.83	0.81	0.12	-0.95	-0.56	0.67	0.96	0.02	0.58	0.24	0.9	-0.53	0.66	0.76		-0.98	0.28	0.72	1.0	0.18	-0.06
Inventory	-0.78	-0.25	-0.53	-0.67	0.32	-0.73	-0.75	-0.11	0.9	0.55	-0.57	-0.91	0.04	-0.54	-0.26	-0.86	0.44	-0.63	-0.74	-0.98		-0.23	-0.69	-0.98	-0.26	0.12
Other Current Assets	0.76	0.9	0.76	0.79	0.32	0.63	0.77	0.96	-0.17	-0.89	0.77	0.24	0.96	0.84	0.89	0.63	-0.7	0.81	0.8	0.28	-0.23		0.82	0.33	0.62	0.92
Other Stockholder Equity	0.97	0.8	0.93	0.98	0.13	0.81	0.96	0.74	-0.6	-0.97	0.89	0.66	0.62	0.95	0.81	0.91	-0.82	0.99	0.98	0.72	-0.69	0.82		0.75	0.69	0.54
Total Liab	0.86	0.27	0.56	0.74	-0.4	0.85	0.83	0.17	-0.95	-0.6	0.7	0.96	0.06	0.62	0.28	0.92	-0.57	0.7	0.79	1.0	-0.98	0.33	0.75		0.22	-0.02
Net Invested Capital	0.49	0.88	0.86	0.63	0.76	0.15	0.5	0.77	0.04	-0.77	0.35	0.03	0.51	0.65	0.88	0.4	-0.38	0.7	0.64	0.18	-0.26	0.62	0.69	0.22		0.49
Long Term Investments	0.47	0.79	0.51	0.49	0.41	0.35	0.5	0.92	0.17	-0.66	0.51	-0.11	0.99	0.58	0.78	0.31	-0.45	0.55	0.54	-0.06	0.12	0.92	0.54	-0.02	0.49

Click cells to compare fundamentals

ATAI Life Account Relationship Matchups

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether ATAI Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ATAI Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atai Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atai Life Sciences Stock:

How To Invest In ATAI

Details

Is ATAI Stock a good investment?

Details

What is ATAI Life's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.97)

Earnings Share

(0.80)

Revenue Per Share

0.002

Quarterly Revenue Growth

(0.54)

Return On Assets

(0.25)

The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATAI Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

ATAI Price To Sales Ratio vs Capex To Operating Cash Flow Analysis

Price To Sales Ratio vs Capex To Operating Cash Flow

Price To Sales Ratio vs Capex To Operating Cash Flow Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Capex To Operating Cash Flow

ATAI Life fundamental ratios Correlations

ATAI Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Non Current Liabilities Total
Net Tangible Assets	+ 0.99	Total Assets
Long Term Investments	+ 0.99	Non Current Assets Total
Other Stockholder Equity	+ 0.99	Common Stock Total Equity
Non Currrent Assets Other	+ 0.98	Total Current Liabilities

Cash	- 1.0	Net Debt
Total Liab	- 0.98	Inventory
Inventory	- 0.98	Non Current Liabilities Total
Other Stockholder Equity	- 0.97	Retained Earnings
Non Currrent Assets Other	- 0.97	Retained Earnings
Retained Earnings	- 0.96	Total Current Liabilities